Imatinib mesylate discontinuation in patients with chronic myelogenous leukaemia in complete molecular remission for more than two years.

被引：0
|
作者：
Rousselot, P
Huguet, F
Cayuela, JM
Maarek, O
Marit, G
Gluckman, E
Reiffers, J
Mahon, FX
机构：
[1] Hop St Louis, Federat Hematol, Paris, France
[2] Hop Mignot, Versailles, France
[3] Hop Purpan, Toulouse, France
[4] Hop Haut Leveque, Bordeaux, France
[5] Inst Bergonie, Bordeaux, France
来源：
BLOOD | 2005年 / 106卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1101
引用
收藏
页码：321A / 321A
页数：1
相关论文
共 50 条
  • [21] Persistence of Leukemia Stem Cells in Chronic Myelogenous Leukemia Patients in Complete Cytogenetic Remission on Imatinib Treatment for 5 Years
    Chu, Su
    Lin, Allen
    McDonald, Tinisha
    Snyder, David S.
    Forman, Stephen J.
    Bhatia, Ravi
    BLOOD, 2008, 112 (11) : 79 - 79
  • [22] Achieving a Complete Molecular Remission Under Imatinib Therapy Is Associated with a Better Outcome in Chronic Phase Chronic Myeloid Leukaemia Patients On Imatinib Frontline Therapy
    Etienne, Gabriel
    Nicolini, Nicolini E.
    Dulucq, Stephanie
    Schmitt, Anna
    Hayette, Sandrine
    Lippert, Eric
    Tigaud, Isabelle
    Morisset, Stephane
    Bureau, Caroline
    Adiko, Didier
    Marit, Gerald
    Reiffers, Josy
    Mahon, Francois-Xavier
    BLOOD, 2012, 120 (21)
  • [23] IMATINIB MESYLATE INDUCES HIGH COMPLETE CYTOGENETIC AND MAJOR MOLECULAR RESPONSE RATES IN CHILDREN AND ADOLESCENTS WITH PHILADELPHIA CHROMOSOME-POSITIVE CHRONIC MYELOGENOUS LEUKAEMIA IN CHRONIC PHASE
    Giona, F.
    Putti, M. C.
    Santoro, N.
    Gottardi, E.
    Ladogana, S.
    Micalizzi, C.
    Iaria, G.
    Consarino, C.
    Burnelli, R.
    Rea, M.
    Nanni, M.
    Messina, C.
    Diverio, D.
    Biondi, A.
    Pession, A.
    Saglio, G.
    Foa, R.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 346 - 346
  • [24] Prognostic Factors Associated with Complete Cytogenetic Response in Patients with Chronic Myelogenous Leukemia on Imatinib Mesylate Therapy
    Cojbasic, Irena
    Macukanovic-Golubovic, Lana
    SRPSKI ARHIV ZA CELOKUPNO LEKARSTVO, 2010, 138 (5-6) : 305 - 308
  • [25] Treatment-free remission after imatinib discontinuation is possible in paediatric patients with chronic myeloid leukaemia
    Giona, Fiorina
    Saglio, Giuseppe
    Moleti, Maria Luisa
    Piciocchi, Alfonso
    Rea, Massimiliano
    Nanni, Mauro
    Marzella, Deborah
    Testi, Anna Maria
    Mariani, Sabrina
    Laurino, Marica
    Diverio, Daniela
    Gottardi, Enrico
    Foa, Robin
    BRITISH JOURNAL OF HAEMATOLOGY, 2015, 168 (02) : 305 - 308
  • [26] Sequential transient novel chromosomal translocations in a patient with chronic myelogenous leukemia in complete cytogenetic remission after therapy with imatinib mesylate
    Papaioannou, George
    Athanasiadou, Anastasia
    Voutiadou, Georgia
    Gaitatzi, Maria
    Batsis, Ioannis
    Touloumenidou, Tasoula
    Anagnostopoulos, Achilles
    CANCER GENETICS, 2011, 204 (12) : 692 - 693
  • [27] Quality of peripheral blood stem cells collected from patients in complete cytogenetic remission of chronic myeloid leukaemia after imatinib mesylate treatment
    Marin, P
    Carrió, A
    Colomer, D
    Lozano, M
    Carreras, E
    Petriz, J
    Cervantes, F
    Ordinas, A
    Montserrat, E
    BONE MARROW TRANSPLANTATION, 2003, 31 : S165 - S165
  • [28] Successful maintenance of molecular remission in chronic myelogenous leukaemia during pregnancy with transition from imatinib to pegylated interferon
    Ellis, M.
    Mills, A. K.
    INTERNAL MEDICINE JOURNAL, 2015, 45 (03) : 358 - 359
  • [29] Discontinuation of imatinib in children with chronic myeloid leukaemia in sustained deep molecular remission: results of the STOP IMAPED study
    de Bruijn, Clara M. A.
    Millot, Frederic
    Suttorp, Meinolf
    Borisevich, Marina
    Brons, Paul
    Lausen, Birgitte
    de Bont, Eveline S. J. M.
    BRITISH JOURNAL OF HAEMATOLOGY, 2019, 185 (04) : 718 - 724
  • [30] Hematopathologic and cytogenetic findings in imatinib mesylate treated chronic myelogenous leukemia patients: 2.5 years' experience
    Cojbasic, Irena
    Macukanovic-Golubovic, Lana
    VOJNOSANITETSKI PREGLED, 2010, 67 (10) : 802 - 806
12345